Key Details
Price
$1.00Annual EPS
-$2.70Annual ROE
-140.36%Beta
0.67Events Calendar
Next earnings date:
Apr 15, 2025Recent quarterly earnings:
Nov 04, 2024Recent annual earnings:
Apr 15, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Oct 20, 2022Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2024.
UNITY Biotechnology (UBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2024.
SAN FRANCISCO, July 22, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced the appointment of Alicia Tozier, MBA, as chief strategy officer. In this new role, she will develop and implement the company's corporate and product strategies.
There is increasing optimism about UNITY Biotechnology's earnings prospects, leading to its upgrade to a Zacks Rank #2 (Buy) and potential for a rise in stock price.
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.
Unity Biotechnology (NASDAQ: UBX ) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. UBX1325 is a treatment in development by the company that it's testing for use with patients suffering from wet age-related macular degeneration ( AMD ).
FAQ
- What is the primary business of Unity Biotechnology?
- What is the ticker symbol for Unity Biotechnology?
- Does Unity Biotechnology pay dividends?
- What sector is Unity Biotechnology in?
- What industry is Unity Biotechnology in?
- What country is Unity Biotechnology based in?
- When did Unity Biotechnology go public?
- Is Unity Biotechnology in the S&P 500?
- Is Unity Biotechnology in the NASDAQ 100?
- Is Unity Biotechnology in the Dow Jones?
- When was Unity Biotechnology's last earnings report?
- When does Unity Biotechnology report earnings?
- Should I buy Unity Biotechnology stock now?